NCT04485949 2026-02-10
A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
Imvax
Phase 2 Active not recruiting
Imvax
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Heinrich-Heine University, Duesseldorf